| Ident. | Authors (with country if any) | Title |
|---|
| 000163 |
V. Mendes Martins [France] ; J. Coste [France] ; P. Derost [France] ; M. Ulla [France] ; J. Gabrillargues [France] ; F. Durif [France] ; J. Chazal [France] ; J.-J. Lemaire [France] | Complications chirurgicales de la stimulation cérébrale profonde: expérience clinique à propos de 184 cas |
| 000476 |
P. Payoux [France] ; C. Brefel-Courbon [France] ; F. Ory-Magne [France] ; W. Regragui [France] ; C. Thalamas [France] ; S. Balduyck [France] ; F. Durif [France] ; J. P. Azulay [France] ; F. Tison [France] ; O. Blin [France] ; J. P. Esquerre [France] ; O. Rascol [France] | Motor activation in multiple system atrophy and Parkinson disease: A PET study |
| 000530 |
C. Ardouin [France] ; I. Chereau [France] ; P.-M. Llorca [France] ; E. Lhommee [France] ; F. Durif [France] ; P. Pollak [France] ; P. Krack [France] | Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson |
| 000600 |
S. Bannier [France] ; C. Montaurier [France] ; P. P. Derost [France] ; M. Ulla [France] ; J.-J. Lemaire [France] ; Y. Boirie [France] ; B. Morio [France] ; F. Durif [France] | Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease : long term follow-up |
| 000660 |
J.-P. Azulay [France] ; F. Durif [France] ; R. Rogez [France] ; C. Tranchant [France] ; I. Bourdeix [France] ; K. Rerat [France] | Étude Précoce : évaluation d'un autoquestionnaire de dépistage et prise en charge précoces des fluctuations dans la maladie de Parkinson |
| 000721 |
S. Lesage [France] ; E. Lohmann [France] ; F. Tison [France] ; F. Durif [France] ; A. Dürr [France] ; A. Brice [France] | Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls |
| 000878 |
C. Montaurier [France] ; B. Mono [France] ; S. Bannier [France] ; P. Derost [France] ; P. Arnaud [France] ; M. Brandolini-Bunlon [France] ; C. Giraudet [France] ; Y. Boirie [France] ; F. Durif [France] | Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation |
| 000886 |
P.-P. Derost [France] ; L. Ouchchane [France] ; D. Morand [France] ; M. Ulla [France] ; P.-M. Llorca [France] ; M. Barget [France] ; B. Debilly [France] ; J.-J. Lemaire [France] ; F. Durif [France] | Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? |
| 000928 |
F. Caire [France] ; Ph. Derost [France] ; J. Coste [France] ; J.-M. Bonny [France] ; F. Durif [France] ; E. Frenoux [France] ; A. Villeger [France] ; J.-J. Lemaire [France] | Stimulation sous-thalamique dans la maladie de parkinson sévère : Etude de la localisation des contacts effectifs |
| 000999 |
M. Ulla [France] ; S. Thobois [France] ; J.-J. Lemaire [France] ; A. Schmitt [France] ; P. Derost [France] ; E. Broussolle [France] ; P.-M. Llorca [France] ; F. Durif [France] | Manic behaviour induced by deep-brain stimulation in Parkinson's disease : evidence of substantia nigra implication? |
| 000C62 |
P. Pollak [France] ; F. Tison [France] ; O. Rascol [France] ; A. Destee [France] ; J. J. Pere [France] ; J. M. Senard [France] ; F. Durif [France] ; I. Bourdeix [France] | Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up |
| 000C63 |
F. Durif [France] ; B. Debilly [France] ; M. Galitzky [France] ; D. Morand [France] ; F. Viallet [France] ; M. Borg [France] ; S. Thobois [France] ; E. Broussolle [France] ; O. Rascol [France] | Clozapine improves dyskinesias in Parkinson disease: A double-blind, placebo-controlled study |
| 000C71 |
P. Ibanez [France] ; E. Lohmann [France] ; P. Pollak [France] ; F. Durif [France] ; C. Tranchant [France] ; Yves Agid [France] ; A. Dürr [France] ; A. Brice [France] | Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease |
| 000C85 |
F. Ghawche [France] ; F. Durif [France] | Traitement dopaminergique et syndromes parkinsoniens |
| 000D81 |
G. Fenelon [France] ; S. Gimenez-Roldan [Espagne] ; J. L. Montastruc [France] ; F. Bermejo [Espagne] ; F. Durif [France] ; I. Bourdeix [France] ; J.-J. Pere [Espagne] ; L. Galiano [Suisse] ; J. Schadrack | Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study |
| 000E10 |
C. Chassain [France] ; A. Eschalier [France] ; F. Durif [France] | Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeys |
| 000E63 |
F. Durif [France] | Fluctuations motrices |
| 001070 |
F. Durif [France] ; I. Devaux [France] ; J.-J. Pere [France] ; J.-C. Delumeau [Suisse] ; I. Bourdeix [France] | Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's Disease and end-of-dose deterioration in daily medical practice : An open, multicenter study |
| 001092 |
C. Chassain [France] ; A. Eschalier [France] ; F. Durif [France] | Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP |
| 001287 |
F. Durif [France] ; M. Vidailhet [France] ; B. Debilly [France] ; Yves Agid [France] | Worsening of levodopa-induced dyskinesias by motor and mental tasks |
| 001297 |
M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France] | The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease |
| 001352 |
J. J. Lemaire [France] ; F. Durif [France] ; J. Y. Boire [France] ; B. Debilly [France] ; B. Irthum [France] ; J. Chazal [France] ; D. Thomas ; C. Ostertag | Direct stereotactic MRI location in the globus pallidus for chronic stimulation in Parkinson's disease. Commentaries |
| 001366 |
F. Durif [France] ; J.-J. Lemaire [France] ; B. Debilly [France] ; G. Dordain [France] | Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease |
| 001543 |
Yves Agid [France] ; A. Destee ; F. Durif ; J.-L. Montastruc ; P. Pollak | Tolcapone, bromocriptine, and Parkinson's disease |
| 001555 |
E. Courty [France] ; F. Durif [France] ; M. Zenut [France] ; P. Courty [France] ; J. Lavarenne [France] | Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease |
| 001567 |
F. Durif [France] ; M. Vidailhet [France] ; F. Assal [France] ; C. Roche [France] ; A. M. Bonnet [France] ; Yves Agid [France] | Low-dose clozapine improves dyskinesias in Parkinson's disease |
| 001582 |
F. Coudore [France] ; F. Durif [France] ; E. Duroux [France] ; A. Eschalier [France] ; J. Fialip [France] | Effect of tolcapone on plasma and striatal apomorphine disposition in rats |
| 001723 |
F. Durif [France] ; M. Vidailhet ; A. M. Bonnet ; J. Blin ; Yves Agid [France] | Levodopa-induced dyskinesias are improved by fluoxetine |
| 001827 |
E. Courty [France] ; F. Durif [France] ; P. Courty [France] ; A.-J. Coudert [France] | Sexe, délire et Parkinson: un effet inattendu de l'apomorphine? Réflexion à propos de quatre observations |
| 001867 |
F. Durif [France] ; M. Paire [France] ; D. Deffond [France] ; A. Eschalier [France] ; G. Dordain [France] ; M. Tournilhac [France] ; J. Lavarenne [France] | Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's disease |
| 001898 |
D. Deffond [France] ; F. Durif ; M. Tournilhac | Apomorphine in treatment of Parkinson's disease : comparison between subcutaneous and sublingual routes |
| 001941 |
F. Durif [France] ; D. Deffond [France] ; A. Eschalier [France] ; M. Tournilhac [France] | Administration de l'apomorphine par voie subliguale dans le traitement des fluctuations motrices de la maladie de Parkinson |
| 001949 |
F. Durif [France] ; P. Pollak [France] ; M. Hommel ; C. Ardouin ; J. F. Le Bas ; G. Crouzet ; J. Perret | Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease |
| 001A03 |
F. Durif [France] ; E. Jeanneau [France] ; F. Serre-Debeauvais ; D. Deffond ; A. Eschalier [France] ; M. Tournilhac | Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease |
| 001A77 |
D. Vernay ; A. Eschalier ; F. Durif ; O. Aumaitre ; B. Rigal ; A. Ben Sadoun ; J. Fialip ; H. Marty ; E. Philip ; A. M. Bougerolle ; P. Dostert ; M. Strolin Benedetti ; G. Dordain | Le salsolinol, molécule endogène: possibles implications dans l'alcoolisme, la maladie de Parkinson et la douleur |
